指南与共识消化道肿瘤与早癌消化内镜

结直肠癌关键研究空白及研究优先领域建议:以改善预防与结局

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
指南 / 共识 · Gut · 2018-01-01

本文由多学科小组(含患者、临床医生与研究者,n=71)通过分析识别结直肠癌关键研究空白(RG)并提出研究建议(RR),最终总结15项关键RG,涵盖从发现科学、预防、筛查、病理、治疗到生存者管理的全链条,旨在通过优先研究投入降低疾病负担。

要点

  • 多学科小组识别出15项结直肠癌关键研究空白(RG),覆盖预防、筛查、诊断、治疗及生存管理。
  • RG包括缺乏真实模型、预防试验不足、筛查策略不优、病理评估不精确及生物标志物缺乏等。
  • 优先研究投入可能在未来5年显著降低结直肠癌疾病负担。

核心结论

  • 优先安排研究活动与资助可能在未来5年对降低结直肠癌疾病负担产生显著影响。

研究设计与样本

  • 由患者、临床医生和研究者组成的多学科小组(n=71)进行RG分析,设8个工作组:发现科学、风险、预防、早期诊断与筛查、病理、治愈性治疗、IV期疾病、结直肠癌生存与后续管理;各工作组经讨论形成草案,由20人患者小组评估,最终RG与RR清单获所有参与者认可。

主要发现

  • 总结15项关键RG:RG1缺乏能重现肿瘤/肿瘤微/宏环境的真实模型;RG2遗传/环境/生活方式因素对结直肠癌风险精确贡献的证据不足;RG3迫切需要预防试验;RG4缺乏不同预防方法的整合;RG5缺乏结直肠癌筛查的最佳策略;RG6缺乏侵入性检查的有效分诊系统;RG7结直肠癌病理评估不精确;RG8缺乏基因组学、数据科学和数字病理的合格人员;RG9对治疗选择的风险、获益和不确定性评估/沟通不足;RG10需要新技术/干预改善治愈性结局;RG11缺乏识别转移肿瘤与其微环境分子相互作用的方法;RG12缺乏指导IV期治疗的可靠生物标志物;RG13需要加深对健康相关生活质量(HRQOL)的理解并促进残留症状解决;RG14结直肠癌研究/资助缺乏协调;RG15相关利益方之间缺乏有效沟通。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Colorectal cancer (CRC) leads to significant morbidity/mortality worldwide. Defining critical research gaps (RG), their prioritisation and resolution, could improve patient outcomes. DESIGN: RG analysis was conducted by a multidisciplinary panel of patients, clinicians and researchers (n=71). Eight working groups (WG) were constituted: discovery science; risk; prevention; early diagnosis and screening; pathology; curative treatment; stage IV disease; and living with and beyond CRC. A series of discussions led to development of draft papers by each WG, which were evaluated by a 20-strong patient panel. A final list of RGs and research recommendations (RR) was endorsed by all participants. RESULTS: Fifteen critical RGs are summarised below: RG1: Lack of realistic models that recapitulate tumour/tumour micro/macroenvironment; RG2: Insufficient evidence on precise contributions of genetic/environmental/lifestyle factors to CRC risk; RG3: Pressing need for prevention trials; RG4: Lack of integration of different prevention approaches; RG5: Lack of optimal strategies for CRC screening; RG6: Lack of effective triage systems for invasive investigations; RG7: Imprecise pathological assessment of CRC; RG8: Lack of qualified personnel in genomics, data sciences and digital pathology; RG9: Inadequate assessment/communication of risk, benefit and uncertainty of treatment choices; RG10: Need for novel technologies/interventions to improve curative outcomes; RG11: Lack of approaches that recognise molecular interplay between metastasising tumours and their microenvironment; RG12: Lack of reliable biomarkers to guide stage IV treatment; RG13: Need to increase understanding of health related quality of life (HRQOL) and promote residual symptom resolution; RG14: Lack of coordination of CRC research/funding; RG15: Lack of effective communication between relevant stakeholders. CONCLUSION: Prioritising research activity and funding could have a significant impact on reducing CRC disease burden over the next 5 years.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lawler M, Alsina D, Adams RA, et al. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut. 2018. PMID: 29233930. doi:10.1136/gutjnl-2017-315333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。